Concepedia

A. C. SAU

AC

Statistics

Publications

9

Citations

349

H-Index

9

Active since

1975

Affiliations

University of Rome Tor Vergata(Current)

Bambino Gesù Children's Hospital

Istituti di Ricovero e Cura a Carattere Scientifico

University of Ottawa

Istituto Superiore di Sanità

A. C. SAU is an author at University of Rome Tor Vergata specializing in pharmacology, oncology, and cancer pharmacology.

ORCID

Publications per year

1975–2016

9

Publications

9

Persistent Activation of NF-κB in BRCA1-Deficient Mammary Progenitors Drives Aberrant Proliferation and Accumulation of DNA Damage

A. C. SAU, Rosanna Lau, Miguel A. Cabrita et al. · Cell stem cell · 2016 · 116 citations · Full text

, , +17

Targeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and -resistant human osteosarcoma cell lines

A. C. SAU, Giuseppe Filomeni, Silvia Pezzola et al. · Molecular BioSystems · 2011 · 72 citations · Full text

, , +17

The glutathione transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) increases temozolomide efficacy against malignant melanoma

Lucio Tentori, Annalisa Susanna Dorio, Emanuela Mazzon et al. · European Journal of Cancer · 2011 · 38 citations · Full text

, , +11

In vitro and in vivo efficacy of 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) on human melanoma

Francesca Pellizzari Tregno, A. C. SAU, Silvia Pezzola et al. · European Journal of Cancer · 2009 · 34 citations · Full text

, , +4

The glutathione S-transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol overcomes the MDR1-P-glycoprotein and MRP1-mediated multidrug resistance in acute myeloid leukemia cells

Alessandro Ascione, Maurizio Cianfriglia, Maria Luisa Dupuis et al. · Cancer Chemotherapy and Pharmacology · 2009 · 30 citations

, , +13

1–5 of 9